IVIG continues to be in short supply.  Supply is less than the demand, in part to the growing number of primary immune deficiency disease; off-label treatment uses, and increased geriatric population that is disposed to antibody deficiency disorders.  Usage is estimated to grow around 7% or more through 2022.

Some conservation suggestions:

• Conservation
  • Reduce/Avoid waste
  • Prepare when patient arrives
  • Batch if have more than one patient
  • Round to the nearest vial size staying within 10% of the prescribed dose.
• Work with provider to ensure appropriate use
  • Set up parameters via P&T/Medical Staff Committee

Contact PHV with questions or for further assistance.